An emerging nano-medicine company, Nanobiotix,  with its focus on development of therapies for cancer, has announced that the European Patent Office (EPO) has issued a patent for its “novel activable particles” which can be useful in the medical sector.
The patent seeks to protect composite particles which have ability to generate heat when energized by X-rays. There use in the development of treatments for diseases in particularly human beings is also patented. Designed to destroy cancer cells precisely through the controlled application of an external source of energy, the NanoXray will advance the treatment of cancer in human body.

Researchers at University of Rochester Medical Center have found that an antioxidant that occurs naturally in wine may reach and destroy mitochondria, thereby destroying the pancreatic cancer cells. The researchers further say that the link between the mitochondria and antioxidant is significant, since mitochondria has its own DNA and is the core power supplier for the cells.